Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday
KeyBanc Sees Hospitals Beating/raising With Q3 Earnings
Ardent Health Partners Price Target Announced at $24.00/Share by Keybanc
KeyBanc Initiates Ardent Health Partners at Overweight
Ardent Health Partners With Qventus To Drive Strategic Perioperative Growth; Health System Leverages Qventus' AI-Powered Solutions To Optimize Its Robotics Program And Drive Case Volume
Ardent Health Added To Russell 2000 And 3000 Indexes
RBC Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $23
RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)
Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $24 Price Target
Ardent Health Partners Analyst Ratings
Express News | Ardent Health Completes Term Loan Repricing
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)
Ambarella, Bill Holdings And Box Are Among Top 7 Mid Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Express News | Ardent Health Partners Inc : JP Morgan Raises Target Price to $19 From $18
NYSE New 52-Week Highs And Lows
Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $22
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success
Truist Financial Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Loop Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Raises Target Price to $21
Loop Capital analyst Timothy Greaves maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and adjusts the target price from $18 to $21.According to TipRanks data, the analyst has a success
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $22
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and sets the target price at $22.According to TipRanks data, the analyst has a success rate